The American Medical Association innovation subsidiary Health2047 has spun off a company that uses personalized medicine to fight obesity.

Phenomix Sciences is a phenotype testing company that carries out the AMA’s mission to confront chronic diseases such as obesity.

Phenomix uses a blood test called MyPhenome that it has licensed from the Mayo Clinic to allow doctors to prescribe individualized therapies. MyPhenome measures DNA as well as a person’s metabolites and hormones. These biomarkers make up a person’s phenotype, according to Phenomix.

Clinical-grade cognitive rehabilitation program personalized by clinicians using AI-powered tools.

FOUNDED

2023

website

Cybersecurity situational awareness platform for healthcare.

FOUNDED

2021

AI foundation model infrastructure for medical imaging applications.

FOUNDED

2018

WEBSITE

from the studio

From symptoms to systems: investing in the health of women

Healthy Returns: a monthly newsletter for founders